Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
Study type: Interventional What is this?
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Scottsdale/Phoenix, Arizona: 12-007710
- Rochester, Minnesota: 12-007710
NCT ID: NCT01728116
Sponsor Protocol Number: 09-1
About this study
To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.
See eligibility criteria
- HbA1c ≥ 7.5% and ≤ 10%
- BMI ≥ 30 and ≤ 55
- Diagnosis of type 1 diabetes mellitus or having any history of ketoacidosis
- C-peptide < 1.0 ng/mL
- Previous GI surgery or abnormal GI anatomical finding
- Prescription antithrombotic therapy (e.g. anticoagulant or antiplatelet agent)
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.